These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 29273078)

  • 21. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Olfactory dysfunction in the APP/PS1 transgenic mouse model of Alzheimer's disease: Morphological evaluations from the nose to the brain.
    Yao ZG; Hua F; Zhang HZ; Li YY; Qin YJ
    Neuropathology; 2017 Dec; 37(6):485-494. PubMed ID: 28643854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sex Dimorphism Profile of Alzheimer's Disease-Type Pathologies in an APP/PS1 Mouse Model.
    Jiao SS; Bu XL; Liu YH; Zhu C; Wang QH; Shen LL; Liu CH; Wang YR; Yao XQ; Wang YJ
    Neurotox Res; 2016 Feb; 29(2):256-66. PubMed ID: 26707129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plaques, tangles, and memory loss in mouse models of neurodegeneration.
    Eriksen JL; Janus CG
    Behav Genet; 2007 Jan; 37(1):79-100. PubMed ID: 17072762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A decade of modeling Alzheimer's disease in transgenic mice.
    McGowan E; Eriksen J; Hutton M
    Trends Genet; 2006 May; 22(5):281-9. PubMed ID: 16567017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model.
    Holtzman DM; Fagan AM; Mackey B; Tenkova T; Sartorius L; Paul SM; Bales K; Ashe KH; Irizarry MC; Hyman BT
    Ann Neurol; 2000 Jun; 47(6):739-47. PubMed ID: 10852539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurodegenerative Alzheimer-like pathology in PDAPP 717V-->F transgenic mice.
    Chen KS; Masliah E; Grajeda H; Guido T; Huang J; Khan K; Motter R; Soriano F; Games D
    Prog Brain Res; 1998; 117():327-34. PubMed ID: 9932418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic hyperglycemia induced via the heterozygous knockout of Pdx1 worsens neuropathological lesion in an Alzheimer mouse model.
    Guo C; Zhang S; Li JY; Ding C; Yang ZH; Chai R; Wang X; Wang ZY
    Sci Rep; 2016 Jul; 6():29396. PubMed ID: 27406855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allicin ameliorates cognitive impairment in APP/PS1 mice via Suppressing oxidative stress by Blocking JNK Signaling Pathways.
    Zhang H; Wang P; Xue Y; Liu L; Li Z; Liu Y
    Tissue Cell; 2018 Feb; 50():89-95. PubMed ID: 29429523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of memory loss in Abeta and tau mouse models.
    Ashe KH
    Biochem Soc Trans; 2005 Aug; 33(Pt 4):591-4. PubMed ID: 16042551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-truncated Aβ
    Wirths O; Walter S; Kraus I; Klafki HW; Stazi M; Oberstein TJ; Ghiso J; Wiltfang J; Bayer TA; Weggen S
    Alzheimers Res Ther; 2017 Oct; 9(1):80. PubMed ID: 28978359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer's disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition.
    Stumm C; Hiebel C; Hanstein R; Purrio M; Nagel H; Conrad A; Lutz B; Behl C; Clement AB
    Neurobiol Aging; 2013 Nov; 34(11):2574-84. PubMed ID: 23838176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mouse models of Alzheimer's disease: the long and filamentous road.
    Phinney AL; Horne P; Yang J; Janus C; Bergeron C; Westaway D
    Neurol Res; 2003 Sep; 25(6):590-600. PubMed ID: 14503012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Animal models of cerebral amyloid angiopathy.
    Jäkel L; Van Nostrand WE; Nicoll JAR; Werring DJ; Verbeek MM
    Clin Sci (Lond); 2017 Oct; 131(19):2469-2488. PubMed ID: 28963121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraneuronal APP and extracellular Aβ independently cause dendritic spine pathology in transgenic mouse models of Alzheimer's disease.
    Zou C; Montagna E; Shi Y; Peters F; Blazquez-Llorca L; Shi S; Filser S; Dorostkar MM; Herms J
    Acta Neuropathol; 2015 Jun; 129(6):909-20. PubMed ID: 25862638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overview of Transgenic Mouse Models for Alzheimer's Disease.
    Myers A; McGonigle P
    Curr Protoc Neurosci; 2019 Sep; 89(1):e81. PubMed ID: 31532917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review: Neuropathology and behavioural features of transgenic murine models of Alzheimer's disease.
    Ameen-Ali KE; Wharton SB; Simpson JE; Heath PR; Sharp P; Berwick J
    Neuropathol Appl Neurobiol; 2017 Dec; 43(7):553-570. PubMed ID: 28880417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Updates on mouse models of Alzheimer's disease.
    Zhong MZ; Peng T; Duarte ML; Wang M; Cai D
    Mol Neurodegener; 2024 Mar; 19(1):23. PubMed ID: 38462606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alzheimer's in 3D culture: challenges and perspectives.
    D'Avanzo C; Aronson J; Kim YH; Choi SH; Tanzi RE; Kim DY
    Bioessays; 2015 Oct; 37(10):1139-48. PubMed ID: 26252541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transgenic mouse models of Alzheimer's disease.
    Hock BJ; Lamb BT
    Trends Genet; 2001 Oct; 17(10):S7-12. PubMed ID: 11585670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.